Primitive study of LINC01270 in esophageal cancer implicated that LINC01270 overexpression pathologically associated with the booster cancer characteristic and the robust drug-resistance against 5-fluorouracil, by modulating glutathione S-transferase P1 (GSTP1) methylation [36]. This evidence concerns the gene GSTP1 and cancer.